| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.41 | 2e-23 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.37 | 1e-19 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.41 | 6e-19 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.36 | 9e-19 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.35 | 5e-15 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.41 | 6e-15 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.29 | 8e-14 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.3 | 7e-13 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.34 | 1e-12 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.32 | 1e-12 |